NCT00436384

Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 150 (planned)
• Sponsor: University Health Network, Toronto · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cytomegalovirus (CMV) is a common cause of illness in patients who have undergone a transplant. Serious infections due to CMV can affect many parts of the body including the lungs, the gut, and the liver. Since transplant recipients are at risk for CMV or have evidence of infection with CMV, they are given an antiviral drug (usually ganciclovir or valganciclovir). Despite this, there are a chance that CMV infection may cause problems in the future. The purpose of this study is to assess how well patients'immune systems responds to the CMV virus, so that in the future it may be possible to predict which patients are at highest risk of CMV.

Conditions

• Transplant

Interventions

Type	Name	Description
PROCEDURE	Monitoring-blood samples drawn for CMV testing

Timeline

• Start date: 2005-11-01
• Primary completion: 2008-03-01
• Completion: 2008-03-01
• First posted: 2007-02-19
• Last updated: 2008-04-16

Locations

1 site across 1 country: Canada